Global Head & Neck Cancer Diagnostics Market
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Global Head & Neck Cancer Diagnostics Market by Diagnostic Method (Bioscopy Screening, Blood Tests, Dental Diagnostic), End User (Diagnostic Centers, Hospitals) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The Global Head & Neck Cancer Diagnostics Market is on a rapid trajectory of growth, with estimations indicating a remarkable journey from USD 1.49 billion in 2022 to USD 1.74 billion in 2023.
The market is forecasted to maintain a Compound Annual Growth Rate (CAGR) of 16.76%, ultimately achieving a substantial valuation of USD 5.16 billion by 2030.
Market Segmentation & Coverage:
A recent research report has dissected the Global Head & Neck Cancer Diagnostics Market, providing comprehensive insights into various aspects of the industry:
Diagnostic Method: The market is extensively studied across diverse diagnostic methods, including Bioscopy Screening, Blood Tests, Dental Diagnostic, Diagnostic Imaging, and Endoscopy Screening. Notably, Bioscopy Screening is expected to witness significant market share during the forecast period.
End User: The market caters to Diagnostic Centers and Hospitals, with Diagnostic Centers projected to dominate the market share during the forecast period.
Region: A geographical analysis spans across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas, specifically Argentina, Brazil, Canada, Mexico, and the United States, led the market in 2022, commanding a substantial market share of 38.74%, followed closely by Europe, Middle East & Africa.
Several factors are propelling the remarkable growth of the Global Head & Neck Cancer Diagnostics Market:
Drivers: The prevalence of head and neck cancer worldwide is a driving force behind market expansion. Additionally, government and private initiatives for cancer diagnostics and increased approvals for head & neck cancer diagnostics contribute significantly to market growth.
Restraints: Challenges in the form of the high cost of devices and unfavorable reimbursement scenarios have been noted.
Opportunities: The market is ripe with opportunities, driven by new advancements and innovations in diagnostic methodology and substantial research funding in oncological advancement.
Challenges: A key challenge identified is the dearth of trained professionals in the field.
The comprehensive report provides invaluable insights into various aspects of the market:
Market Penetration: In-depth information about the market offered by key players.
Market Development: Analysis of lucrative emerging markets and penetration across mature segments of the market.
Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
Market Trends: An understanding of the cumulative impact of COVID-19, the Russia-Ukraine Conflict, and high inflation on the market.
Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
Product Development & Innovation: Insights on future technologies, R&D activities, and breakthrough product developments.
The report also addresses key questions:
What is the market size and forecast of the Global Head & Neck Cancer Diagnostics Market?
What are the inhibiting factors and the impact of COVID-19 shaping the market during the forecast period?
Which products/segments/applications/areas present investment opportunities in the Global Head & Neck Cancer Diagnostics Market?
What is the competitive strategic window for opportunities in the market?
What are the technology trends and regulatory frameworks in the market?
What is the market share of the leading vendors in the Global Head & Neck Cancer Diagnostics Market?
What modes and strategic moves are considered suitable for entering the market?
Number of Pages: 181
Forecast Period: 2023 - 2030
Estimated Market Value (USD) in 2023: $1.74 Billion
Forecasted Market Value (USD) by 2030: $5.16 Billion
Compound Annual Growth Rate: 16.7%
Regions Covered: Global
Bristol Myers Squibb Company
Carestream Health Inc. by Koninklijke Philips N.V.
FUJIFILM Holdings Corporation
General Electric Company
KARL STORZ SE & Co. KG
Xoran Technologies LLC
For more information about this report visit https://www.researchandmarkets.com/r/ekvzz0
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900